Peptron's PT105, a sustained-release Leuprolide, established the bioequivalence with Takeda's Leuplin
Peptron's PT105, a sustained-release Leuprolide, established the bioequivalence with Takeda's Leuplin. Global and regional deal to be initiated. PT105 represents Korea's first commercialized generic...